After a good second quarter Gerresheimer raises its revenue forecast again

Group revenues rise 10.3 percent to EUR 314.0m in Q2 2012 Adjusted EBITDA increases by 4.3 percent to EUR 58.6m Net income rises to EUR 17.4m and EPS to EUR 0.51 Revenue forecast raised from 7 to 8 percent to 9 to 10 percent at constant exchange ratesExpected investment volume rises from around EUR 100m to around EUR 120m Düsseldorf, July 11, 2012 – The robust revenue growth trend continues at Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry. “Our revenues continued to develop very positively in the second quarter of 2012.

This growth is being achieved in the emerging markets with standard glass and plastic pharmaceutical packaging products and in the established markets with sophisticated products for drug dosage and administration. Since we expect the growth trend to continue in the second six months of the year we increase our revenue forecast for 2012 again and are planning substantial investments in these growth markets,” said Uwe Röhrhoff, CEO of Gerresheimer AG.

Gerresheimer has experienced above average growth in revenues in the second quarter of the 2012 financial year (December 1, 2011 to November 30, 2012) of 10.3 percent to EUR 314.0m. At constant exchange rates growth in revenues was 8.1 percent. All divisions contributed to this positive development. South America was one of the strongest regions. Here growth in revenues from plastic containers for tablets, powders, eye drops, nose sprays and other liquid drugs was exceptionally high. Our business with medical plastic systems, such as insulin pen systems and diagnostic instruments, also delivered very solid results. Demand for pre-fillable glass syringes has also developed positively. Revenues from engineering and tools for our product pipeline also made a positive impact on revenue.

Gerresheimer’s adjusted EBITDA was EUR 58.6m in the second quarter of 2012, which is 4.3 percent higher than the prior year figure. The adjusted EBITDA margin was 18.7 percent in the second quarter (prior year 19.8 percent). Net income after tax increased to EUR 17.4m, which is EUR 4.1m higher than the prior quarter figure. Second quarter earnings per share of EUR 0.51 were EUR 0.13 higher than one year ago.

“Our medical plastic systems order book and project pipeline are looking very good at the moment and we will continue to increase our production capacity in this segment. New production facilities are already being constructed at our plants in Pfreimd in Germany and in Horsovsky Tyn in the Czech Republic. And we are already planning the next-but-one extension of our Czech production facility. We will also be investing in our new pharmaceutical glass container plant in India over the coming months. I’m confident that the groundwork we are laying today will take us forward into a very positive future,” commented Uwe Röhrhoff.


In light of the sustained positive development of our business operations and the positive outlook, particularly in the Plastic Systems and Tubular Glass divisions, Gerresheimer is now expecting revenue growth of 9 to 10 percent in the 2012 financial year, assuming that the exchange rates remain constant. This is an upward revision by two percentage points. The company’s operating margin (adjusted EBITDA margin) forecast is still 19.5 percent. A high order volume in the Plastic Systems division led to the company’s decision to increase its 2012 investment budget from approximately EUR 100m to around EUR 120m.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion euros and has around 11.000 employees at 47 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

You can read the online annual report at:

600450 After a good second quarter Gerresheimer raises its revenue forecast again
Date: 16 July 2012

See more news about:

Others also read

The Emirates Arena and Sir Chris Hoy Velodrome have just been completed, creating a new world class sporting landmark for Scotland.
Hawaii and Texas Top List of 20 States and D.C. Adding Construction Jobs Since November 2011 as Delaware and New York Trail; Vermont and Louisiana Led 19 States with One-Month Gain, D.
We sincerely thank all our members, friends and visitors for being part of GlassOnWeb and its success during 2012.
SAGE Electrochromics, Inc., a world leader in the development and manufacture of dynamic glass, located in Faribault, Minn., today announced it has filed a lawsuit in U.S.
The EBRD is providing loans worth €110 million to Turkish glass manufacturer Trakya Cam A.Ş. that will expand its product range at home and in Bulgaria and also establish a presence on the Russian market, setting new standards in energy efficiency.
The United States is honoring its role, to the best of its ability, as the world's locomotive, although despite the positive performance of the real estate market, America seems to be recovering slower than expected.

Add new comment